The benefits of the Oxford-AstraZeneca COVID-19 vaccine outweigh the risks, according to the European Medicines Agency (EMA).
As Crystal Goomansingh explains, the findings come after a small number of people experienced blood clots after getting that shot, prompting multiple countries to suspend using it.